All In MedTech

FDA Clearance Tracker · P980018-S016

HERCAP TEST

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 22, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P980018-S016
Device name
HERCAP TEST
Applicant location
Singapore
Received
Aug 24, 2012
Decided
Feb 22, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P980018

Device type

Device class
Class III

Every decision under product code MVC

FDA's approval statement

As written in FDA's record.

APPROVAL FOR ADDITION OF KADCYLA¿ (ADO-TRASTUZUMAB EMTANSINE) IN THE LABELING OF HERCEP TEST ¿.

Source documents

Other decisions for Agilent Technologies Singapore (International) Pte , Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.